Kathy D. Miller, MD

home / authors / kathy-d-miller-md

Articles

Gemcitabine, Paclitaxel, and Trastuzumab in Metastatic Breast Cancer

Kathy D. Miller, MD;Judy Sisk, RN;Rafat Ansari, MD;Gary Gize, MD;Sreenivasa Nattam, MD;Kenneth Pennington, MD;George W. Sledge, Jr, MD

February 1st 2001

A phase II trial evaluated the effectiveness and toxicity of combination paclitaxel (Taxol), gemcitabine (Gemzar), and trastuzumab (Herceptin) as first-line therapy for patients with newly diagnosed HER2-overexpressing

Expert Consultations in Breast Cancer: Critical Pathways and Clinical Decision Making

William N. Hait, MD, PhD;David A. August, MD;Bruce G. Haffty, MD;Kathy D. Miller, MD

August 1st 2000

This book is the 17th volume in the Basic and Clinical Oncology series edited by Bruce D. Cheson, MD. Like other volumes in this series, Expert Consultations in Breast Cancer follows a unique format and seeks to integrate advances in the basic understanding of breast cancer with promising new therapies and changing health- care economics. The integration of these different perspectives provides both a conceptual and pragmatic framework for clinical decision-making.